KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Q3 2025 value amounting to -$13.8 million.

  • Aurinia Pharmaceuticals' Cash from Investing Activities fell 3026.86% to -$13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.2 million, marking a year-over-year increase of 79491.8%. This contributed to the annual value of $39.3 million for FY2024, which is 68547.57% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Cash from Investing Activities is -$13.8 million, which was down 3026.86% from -$13.3 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Cash from Investing Activities registered a high of $49.2 million during Q1 2024, and its lowest value of -$67.2 million during Q1 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' median Cash from Investing Activities value was -$6.3 million (recorded in 2023), while the average stood at -$6.7 million.
  • In the last 5 years, Aurinia Pharmaceuticals' Cash from Investing Activities surged by 263179.64% in 2022 and then crashed by 58869.47% in 2024.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Cash from Investing Activities stood at -$5.5 million in 2021, then surged by 45.0% to -$3.0 million in 2022, then tumbled by 107.32% to -$6.3 million in 2023, then skyrocketed by 726.87% to $39.2 million in 2024, then tumbled by 135.11% to -$13.8 million in 2025.
  • Its Cash from Investing Activities stands at -$13.8 million for Q3 2025, versus -$13.3 million for Q2 2025 and $31.0 million for Q1 2025.